James W Rocco

5PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Reaction engineering (excl. nuclear reactions)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Sep 12, 2023
Y-27632 acts beyond ROCK inhibition to maintain epidermal stem-like cells in culture.

Travis A Witkowski, Bin Li, Jason G Andersen

|Apr 20, 2023
Inferring early genetic progression in cancers with unobtainable premalignant disease.

Ignaty Leshchiner, Edmund A Mroz, Justin Cha

|Apr 03, 2023
Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma.

Sidharth V Puram, Michael Mints, Ananya Pal

|Mar 28, 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Christine H Chung, Jiannong Li, Conor E Steuer

Pageof 1